✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Omkar Pharmachem Ltd.

OMKARPH

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹29 Cr.
P/E
161.41

Omkar Pharmachem Ltd.

  • Omkar Pharmachem
  • Panjon
  • Chandra Bhagat Pharm

FAQs on Omkar Pharmachem Ltd. Shareprice

Omkar Pharmachem has given better returns compared to its competitors.
Omkar Pharmachem has grown at ~-2.28% over the last 1yrs while peers have grown at a median rate of -27.38%

Yes, Omkar Pharmachem is expensive.
Latest PE of Omkar Pharmachem is 161, while 3 year average PE is 128.
Also latest EV/EBITDA of Omkar Pharmachem is 114 while 3yr average is 85.78.

View FAQ's On Business

Growth Table

  • Omkar Pharmachem Ltd.
  • Panjon
  • Chandra Bhagat Pharm

Balance Sheet

  • Omkar Pharmachem Ltd.
  • Panjon
  • Chandra Bhagat Pharm

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Omkar Pharmachem Ltd.
  • Panjon
  • Chandra Bhagat Pharm

Cash Flow

  • Omkar Pharmachem Ltd.
  • Panjon
  • Chandra Bhagat Pharm

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Omkar Pharmachem Ltd.
  • Panjon
  • Chandra Bhagat Pharm

Quarterly Results

  • Omkar Pharmachem Ltd.
  • Panjon
  • Chandra Bhagat Pharm

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Omkar Pharmachem Ltd. Financials

Balance sheet of Omkar Pharmachem is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Omkar Pharmachem is increasing.
Latest net debt of Omkar Pharmachem is -₹0.06 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹0.1 Crs.

The profit is oscillating.
The profit of Omkar Pharmachem is ₹0.2 Crs for Mar 2025, ₹0.19 Crs for Mar 2024 and ₹0.2 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Omkar Pharmachem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech